What's New
Outcome of the Consultation on the Proposal to Change the Regulatory and Funding Restrictions for Stimulant Treatments for ADHD
Following public consultation with Pharmac, Medsafe has made the decision to change the regulatory restrictions on who can initiate prescribing of stimulant medicines for ADHD.
News and Events
| Date | Type | Title |
|---|---|---|
| 30/6/2025 | Committees | Melatonin without a prescription |
| 24/6/2025 | Consultation | Outcome of the consultation on the proposal to change the regulatory and funding restrictions for stimulant treatments for ADHD |
| 16/6/2025 | Consultation | Topical corticosteroids: Proposal for the package labelling to state their potency |
| 12/6/2025 | Notices | Medsafe industry meetings May 2025 |
| 12/6/2025 | Consultation | Proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Bioequivalence of medicines |
| 10/6/2025 | Committees | Medicines Classification Committee - Dates and Deadlines |
| 10/6/2025 | Committees | Agenda for the 74th meeting of the Medicines Classification Committee to be held on 23 July 2025 |
| 5/6/2025 | Publications | Prescriber Update Vol. 46. No. 2 - June 2025 |
| 30/5/2025 | Alert Communication | Stop using Euky Bear Warm Steam Vaporiser - model number EBSV2013 |
| 5/5/2025 | Notices | Policy Statement - Early notification of potential medicine supply issues |
